RemeGen Co Ltd Sustainability Reports
RemeGen Co., Ltd. is a biopharmaceutical company engaged in the discovery, development, and commercialization of innovative and differentiated biologics. The company primarily focuses on therapeutic antibody drugs, including antibody-drug conjugates (ADCs), fusion proteins, and monoclonal antibodies for oncology and autoimmune diseases.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 300300M9HCX4TFAD4I10
FIGI: BBG00XZZHVT3
11 reports from 2020 to 2025